Funding for this research was provided by:
Russian Foundation for Basic Research (19-015-00122)
Instituto de Salud Carlos III (PI17_01164, CPII17_00006)
Ministerio de Economía y Competitividad (MINECO, SAF2013-46943-R)
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Comunidad de Madrid (CAM, B2017/BMD3721)
Fundación Mutua Madrileña (None)
Fundación Ramón Areces (None)
Received: 20 February 2020
Accepted: 26 July 2020
First Online: 13 August 2020
Ethics approval and consent to participate
: The clinical and molecular genetic study was performed in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Federal State Budgetary Institution “Research Centre for Medical Genetics,” Moscow, Russia, and Ethics Committee of the Fundación Jiménez Díaz University Hospital, Madrid, Spain, with written informed consent being obtained from each participant and/or their legal representative as appropriate.
: Consent for publication was obtained from the legal guardian of the patient.
: The authors declare that they have no competing interests.